These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27988480)

  • 1. Simultaneous quantitation of cytokeratin-19 fragment and carcinoembryonic antigen in human serum via quantum dot-doped nanoparticles.
    Chen Z; Liang R; Guo X; Liang J; Deng Q; Li M; An T; Liu T; Wu Y
    Biosens Bioelectron; 2017 May; 91():60-65. PubMed ID: 27988480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bead-based microarray immunoassay for lung cancer biomarkers using quantum dots as labels.
    Liu L; Wu S; Jing F; Zhou H; Jia C; Li G; Cong H; Jin Q; Zhao J
    Biosens Bioelectron; 2016 Jun; 80():300-306. PubMed ID: 26852198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying strand displacement amplification to quantum dots-based fluorescent lateral flow assay strips for HIV-DNA detection.
    Deng X; Wang C; Gao Y; Li J; Wen W; Zhang X; Wang S
    Biosens Bioelectron; 2018 May; 105():211-217. PubMed ID: 29412945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasensitive Sensor Using Quantum Dots-Doped Polystyrene Nanospheres for Clinical Diagnostics of Low-Volume Serum Samples.
    Chen Z; Li P; Zhang Z; Zhai X; Liang J; Chen Q; Li K; Lin G; Liu T; Wu Y
    Anal Chem; 2019 May; 91(9):5777-5785. PubMed ID: 30943003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High preoperative and postoperative levels of carcinoembryonic antigen and CYFRA 21-1 indicate poor prognosis in patients with pathological Stage I nonsmall cell lung cancer.
    Duan X; Cui Y; Li H; Shi G; Wu B; Liu M; Chang D; Wang T; Kong Y
    Indian J Cancer; 2015 Dec; 52 Suppl 3():E158-63. PubMed ID: 27453414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance characteristics of an automated assay for the quantitation of CYFRA 21-1 in human serum.
    Patel JL; Erickson JA; Roberts WL; Grenache DG
    Clin Biochem; 2010 Dec; 43(18):1449-52. PubMed ID: 20875814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplexed detection of lung cancer biomarkers based on quantum dots and microbeads.
    Wu S; Liu L; Li G; Jing F; Mao H; Jin Q; Zhai W; Zhang H; Zhao J; Jia C
    Talanta; 2016 Aug; 156-157():48-54. PubMed ID: 27260434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorometric immunoassay for the simultaneous determination of the tumor markers carcinoembryonic antigen and cytokeratin 19 fragment using two kinds of CdSe/ZnS quantum dot nanobeads and magnetic beads.
    Ding L; Chen X; He L; Yu F; Yu S; Wang J; Tian Y; Wang Y; Wu Y; Liu LE; Qu L
    Mikrochim Acta; 2020 Feb; 187(3):171. PubMed ID: 32062798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive and Quantitative Detection of C-Reaction Protein Based on Immunofluorescent Nanospheres Coupled with Lateral Flow Test Strip.
    Hu J; Zhang ZL; Wen CY; Tang M; Wu LL; Liu C; Zhu L; Pang DW
    Anal Chem; 2016 Jun; 88(12):6577-84. PubMed ID: 27253137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Tetanus Antibody Applying a Cu-Zn-In-S/ZnS Quantum Dot-Based Lateral Flow Immunoassay.
    Meng HM; Chen J; Qu L; Li Z
    Methods Mol Biol; 2020; 2135():285-292. PubMed ID: 32246343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma.
    Kao CH; Hsieh JF; Ho YJ; Ding HJ
    Lung; 1999; 177(5):333-7. PubMed ID: 10467024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
    Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
    Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
    Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer.
    Okamura K; Takayama K; Izumi M; Harada T; Furuyama K; Nakanishi Y
    Lung Cancer; 2013 Apr; 80(1):45-9. PubMed ID: 23352032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fast and sensitive immunoassay of avian influenza virus based on label-free quantum dot probe and lateral flow test strip.
    Li X; Lu D; Sheng Z; Chen K; Guo X; Jin M; Han H
    Talanta; 2012 Oct; 100():1-6. PubMed ID: 23141303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-femtomolar vertical graphene field effect immunosensor for detection of lung tumor markers.
    Liu R; Song H; Wu H; Yang Z; Fang S; Zhu J; Ba L
    Talanta; 2024 Oct; 278():126498. PubMed ID: 38959668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantages of time-resolved fluorescent nanobeads compared with fluorescent submicrospheres, quantum dots, and colloidal gold as label in lateral flow assays for detection of ractopamine.
    Hu LM; Luo K; Xia J; Xu GM; Wu CH; Han JJ; Zhang GG; Liu M; Lai WH
    Biosens Bioelectron; 2017 May; 91():95-103. PubMed ID: 28006689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening values of carcinoembryonic antigen and cytokeratin 19 fragment for lung cancer in combination with low-dose computed tomography in high-risk populations: Initial and 2-year screening outcomes.
    Triphuridet N; Vidhyarkorn S; Worakitsitisatorn A; Sricharunrat T; Teerayathanakul N; Auewarakul C; Chungklay N; Krongthong W; Luengingkasoot S; Sornsamdang G; Patumanond J; Sritipsukho P
    Lung Cancer; 2018 Aug; 122():243-248. PubMed ID: 30032839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.